Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Tokano

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
British Journal of Rheumatology|February 11, 1999
Circulating interleukin-16 in systemic lupus erythematosusS Lee, H Kaneko, I Sekigawa, et al.
Annals of the Rheumatic Diseases|October 1, 1989
Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosusY Tokano, A Murashima, Y Takasaki, et al.
The Journal of Rheumatology|November 16, 2001
Serum levels of interleukin 15 in patients with rheumatic diseasesJ Suzuki, S Morimoto, H Amano, et al.
Autoimmunity|October 30, 2001
The increased interleukin-13 in patients with systemic lupus erythematosus: relations to other Th1-, Th2-related cytokines and clinical findingsS Morimoto, Y Tokano, H Kaneko, et al.
Scandinavian Journal of Rheumatology|January 1, 1995
Detection of antibodies to HIV-1 gp41- and HLA class II antigen-derived peptides in SLE patientsK Koshino, Y Tokano, T Hishikawa, et al.
The Journal of Rheumatology|January 1, 1993
HLA-DP positive T cells in patients with polymyositis/dermatomyositisY Kanai, Y Tokano, H Tsuda, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 13, 1999
Effective treatment of autoimmune diseases with extremely low dose cyclosporineM Sugiyama, I Sekigawa, Y Tokano, et al.
Arthritis and Rheumatism|June 1, 1997
Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseasesK Nozawa, N Kayagaki, Y Tokano, et al.
Autoimmunity|January 1, 1990
HLA-DP-positive T cells in patients with systemic lupus erythematosusY Tokano, T Hishikawa, T Hirose, et al.
Rheumatology (Oxford, England)|December 28, 2007
Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosusS Nakano, S Morimoto, J Suzuki, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
British Journal of Rheumatology|February 11, 1999
Circulating interleukin-16 in systemic lupus erythematosusS Lee, H Kaneko, I Sekigawa, et al.
Annals of the Rheumatic Diseases|October 1, 1989
Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosusY Tokano, A Murashima, Y Takasaki, et al.
The Journal of Rheumatology|November 16, 2001
Serum levels of interleukin 15 in patients with rheumatic diseasesJ Suzuki, S Morimoto, H Amano, et al.
Autoimmunity|October 30, 2001
The increased interleukin-13 in patients with systemic lupus erythematosus: relations to other Th1-, Th2-related cytokines and clinical findingsS Morimoto, Y Tokano, H Kaneko, et al.
Scandinavian Journal of Rheumatology|January 1, 1995
Detection of antibodies to HIV-1 gp41- and HLA class II antigen-derived peptides in SLE patientsK Koshino, Y Tokano, T Hishikawa, et al.
The Journal of Rheumatology|January 1, 1993
HLA-DP positive T cells in patients with polymyositis/dermatomyositisY Kanai, Y Tokano, H Tsuda, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 13, 1999
Effective treatment of autoimmune diseases with extremely low dose cyclosporineM Sugiyama, I Sekigawa, Y Tokano, et al.
Arthritis and Rheumatism|June 1, 1997
Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseasesK Nozawa, N Kayagaki, Y Tokano, et al.
Autoimmunity|January 1, 1990
HLA-DP-positive T cells in patients with systemic lupus erythematosusY Tokano, T Hishikawa, T Hirose, et al.
Rheumatology (Oxford, England)|December 28, 2007
Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosusS Nakano, S Morimoto, J Suzuki, et al.
Pageof 6